Inhibition of Abeta production by NF-kappaB inhibitors.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neuroscience Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17223266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclooxygenase‐1 and ‐2 enzymes differentially regulate the brain upstream NF‐κB pathway and downstream enzymes involved in prostaglandin biosynthesis

  2006cited by this paper
• Celastrol protects against MPTP‐ and 3‐nitropropionic acid‐induced neurotoxicity

  2005cited by this paper
• The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs.

  2005cited by this paper
• Andrographolide interferes with binding of nuclear factor‐κB to DNA in HL‐60‐derived neutrophilic cells

  2005cited by this paper
• Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production

  2005cited by this paper
• Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease.

  2004cited by this paper
• Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation.

  2003cited by this paper
• Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets

  2003cited by this paper
• Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF‐kB activation

  2003cited by this paper
• Antiinflammatory constituents of Celastrus orbiculatus inhibit the NF-kappaB activation and NO production.

  2002cited by this paper
• Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes.

  2002cited by this paper
• A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

  2001cited by this paper
• Cellular mechanisms of beta-amyloid production and secretion.

  1999cited by this paper
• The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation.

  1998cited by this paper
• NF‐kB immunoreactivity is observed in association with βA4 diffuse plaques in patients with Alzheimer’s disease

  1998cited by this paper
• Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease.

  1997cited by this paper
• Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF‐κB

  1997cited by this paper
• Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B.

  1996cited by this paper
• Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*)

  1995cited by this paper
• Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

  1995cited by this paper

• BET protein inhibitor JQ1 reduces inflammation and hippocampal amyloid-β level without altering Tau phosphorylation in LPS-challenged adult wild-type mice

  2025influential citation
• CRISPR/Cas9-mediated knock-in cells of the late-onset Alzheimer’s disease-risk variant, SHARPIN G186R, reveal reduced NF-κB pathway and accelerated Aβ secretion

  2024cites this paper
• The Double-Edged Effects of Substance P in the Pathology of Alzheimer’s Disease

  2024cites this paper
• Organic Chimeras Based on Selenosugars, Steroids, and Fullerenes as Potential Inhibitors of the β-amyloid Peptide Aggregation.

  2024cites this paper
• Quantification of COX-2 Level in Alzheimer’s Disease Patients to Develop Potential Blood-Based Biomarker for Early Diagnosis and Therapeutic Target

  2024cites this paper
• Pomegranate inhibits neuroinflammation and amyloidogenesis in IL-1β stimulated SK-N-SH cells Original Citation Velagapudi, Ravikanth, Baco, Gina, Khela, Sunjeet, Okorji, Uchechukwu and Olajide, Olumayokun A (2015) Pomegranate inhibits neuroinflammation and amyloidogenesis in IL-1β stimulated SK-N-

  2021cites this paper
• Withaferin-A Treatment Alleviates TAR DNA-Binding Protein-43 Pathology and Improves Cognitive Function in a Mouse Model of FTLD

  2020cites this paper
• Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease.

  2020cites this paper
• 3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice

  2019cites this paper
• Bee Venom Soluble Phospholipase A2 Exerts Neuroprotective Effects in a Lipopolysaccharide-Induced Mouse Model of Alzheimer’s Disease via Inhibition of Nuclear Factor-Kappa B

  2019cites this paper
• Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

  2019cites this paper
• Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease

  2019influential citation
• Palmitate‐induced C/EBP homologous protein activation leads to NF‐κB‐mediated increase in BACE1 activity and amyloid beta genesis

  2018cites this paper
• Network-Driven Proteogenomics Unveils an Aging-Related Imbalance in the Olfactory IκBα-NFκB p65 Complex Functionality in Tg2576 Alzheimer’s Disease Mouse Model

  2017cites this paper
• Phytochemicals as inhibitors of NF‐&kgr;B for treatment of Alzheimer's disease

  2017cites this paper
• Cinnamon, a promising prospect towards Alzheimer's disease

  2017cites this paper
• Diet and Brain Health: Which Role for Polyphenols?

  2017cites this paper
• Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-β Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus

  2016cites this paper
• Pomegranate inhibits neuroinflammation and amyloidogenesis in IL-1β-stimulated SK-N-SH cells

  2016cites this paper
• Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of β-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-κB/BACE1 Signaling Pathways

  2016cites this paper
• Reprint of: Microglial toll-like receptors and Alzheimer’s disease

  2016cites this paper
• Microglial toll-like receptors and Alzheimer's disease.

  2016cites this paper
• Upstream regulators and downstream effectors of NF-κB in Alzheimer's disease.

  2016cites this paper
• Role of TGFβ signaling in the pathogenesis of Alzheimer’s disease

  2015cites this paper
• The role of type 2 diabetes in neurodegeneration.

  2015cites this paper
• Paeoniflorin Atttenuates Amyloidogenesis and the Inflammatory Responses in a Transgenic Mouse Model of Alzheimer’s Disease

  2015cites this paper
• A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder

  2015cites this paper
• Resveratrol decreases the insoluble Aβ1-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats.

  2015cites this paper
• Inflammatory risk factors and pathologies promoting Alzheimer's disease progression: is RAGE the key?

  2015cites this paper
• Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice.

  2015cites this paper
• Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease

  2015cites this paper
• Neuroinflammation in Alzheimer’s disease

  2015cites this paper
• Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer's disease: the NF-κB connection.

  2015cites this paper
• The Spleen Tyrosine Kinase (Syk) Regulates Alzheimer Amyloid-β Production and Tau Hyperphosphorylation*

  2014cites this paper
• Oridonin Attenuates Aβ1–42-Induced Neuroinflammation and Inhibits NF-κB Pathway

  2014cites this paper
• Modulation of Amyloid-β Protein Precursor Expression by HspB1

  2014cites this paper
• Interaction of transactive response DNA binding protein 43 with nuclear factor κB in mild cognitive impairment with episodic memory deficits

  2014cites this paper
• Reducing Effect of IL-32α in the Development of Stroke Through Blocking of NF-κB, but Enhancement of STAT3 Pathways

  2014cites this paper
• Combined Analysis of Phenotypic and Target-Based Screening in Assay Networks

  2014cites this paper
• Neuroprotective properties of curcumin in Alzheimer's disease--merits and limitations.

  2013cites this paper
• Sunitinib enhances neuronal survival in vitro via NF-κB-mediated signaling and expression of cyclooxygenase-2 and inducible nitric oxide synthase

  2013cites this paper
• Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis

  2013cites this paper
• NF-κB Signaling Pathways

  2013cites this paper
• Antimalarial Drug Artemisinin Extenuates Amyloidogenesis and Neuroinflammation in APPswe/PS1dE9 Transgenic Mice via Inhibition of Nuclear Factor‐κB and NLRP3 Inflammasome Activation

  2013cites this paper
• Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.

  2012cites this paper
• Is RAGE still a therapeutic target for Alzheimer's disease?

  2012cites this paper
• Pharmacological inhibition of PKR in APPswePS1dE9 mice transiently prevents inflammation at 12 months of age but increases Aβ42 levels in the late stages of the Alzheimer's disease.

  2012cites this paper
• Nuclear Factor-κB Regulates βAPP and β- and γ-Secretases Differently at Physiological and Supraphysiological Aβ Concentrations*

  2012cites this paper
• Anti-Amyloidogenic Effect of Thiacremonone through Anti-Inflamation In Vitro and In Vivo Models

  2012cites this paper
• NF-kappaB signaling pathways: Role in nervous system physiology and pathology

  2012cites this paper
• A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

  2012cites this paper
• Neuroprotective Effect of L-Theanine on Aβ-Induced Neurotoxicity through Anti-Oxidative Mechanisms in SK-N-SH and SK-N-MC Cells

  2011cites this paper
• Insulin suppresses the expression of amyloid precursor protein, presenilins, and glycogen synthase kinase-3beta in peripheral blood mononuclear cells.

  2011cites this paper
• ERK5: A Novel IKKα-Kinase in Rat Hippocampal Neurons

  2011cites this paper
• Aberrant NF-KappaB Expression in Autism Spectrum Condition: A Mechanism for Neuroinflammation

  2011cites this paper
• Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier

  2011cites this paper
• Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.

  2011cites this paper
• Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanism

  2011cites this paper
• Phagocytosis and LPS alter the maturation state of β-amyloid precursor protein and induce different Aβ peptide release signatures in human mononuclear phagocytes

  2010cites this paper
• Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease

  2010cites this paper
• A 3D-QSAR model based screen for dihydropyridine-like compound library to identify inhibitors of amyloid beta (Aβ) production

  2010cites this paper
• Caveolin-1 Regulates γ-Secretase-Mediated AβPP Processing by Modulating Spatial Distribution of γ-Secretase in Membrane

  2010cites this paper
• Inhibition of Double-Stranded RNA-Dependent Protein Kinase Strongly Decreases Cytokine Production and Release in Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease

  2010cites this paper
• Raf inhibitors as therapeutic agents against neurodegenerative diseases.

  2010cites this paper
• Anti-inflammatory and anti-oxidant neuroprotection in the prevention of Alzheimer's disease

  2010cites this paper
• PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease

  2009cites this paper
• Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice.

  2009cites this paper
• Therapeutic targets for Alzheimer's disease

  2009cites this paper
• Neuroprotective effects of the new diterpene, CBNU06 against beta-amyloid-induced toxicity through the inhibition of NF-kappaB signaling pathway in PC12 cells.

  2009cites this paper
• l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways.

  2009cites this paper
• Phospholipids block nuclear factor-kappa B and tau phosphorylation and inhibit amyloid-beta secretion in human neuroblastoma cells.

  2009cites this paper
• Inhibitory effect of piperlonguminine/ dihydropiperlonguminine on the production of amyloid beta and APP in SK-N-SH cells.

  2009cites this paper
• The IKK-NF- (cid:1) B pathway: a source for novel molecular drug targets in pain therapy?

  2008cites this paper
• NFκB-dependent Control of BACE1 Promoter Transactivation by Aβ42*

  2008cites this paper
• Raf inhibition protects cortical cells against beta-amyloid toxicity.

  2008cites this paper
• The IKK‐NF‐κB pathway: a source for novel molecular drug targets in pain therapy?

  2008cites this paper
• Genes regulated by caloric restriction have unique roles within transcriptional networks.

  2008cites this paper
• The granulocyte macrophage colony stimulating factor (GM-CSF) regulates amyloid beta (Abeta) production.

  2008cites this paper
• β-secretase (BACE1) inhibitors from Perilla frutescens var. acuta

  2008cites this paper
• Dual roles of NF-κB in cell survival and implications of NF-κB inhibitors in neuroprotective therapy

  2007cites this paper
• CD40 promotion of amyloid beta production occurs via the NF‐κB pathway

  2007cites this paper
• Role of Calcium in Inflammation: Relevance to Alzheimer's Disease

  2007cites this paper
• Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy.

  2007cites this paper
• CD40 promotion of amyloid beta production occurs via the NF-kappaB pathway.

  2007cites this paper